Your browser doesn't support javascript.
loading
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy.
Vaflard, Pauline; Paoletti, Xavier; Servois, Vincent; Tresca, Patricia; Pons-Tostivint, Elvire; Sablin, Marie-Paule; Ricci, Francesco; Loirat, Delphine; Hescot, Ségolène; Torossian, Nouritza; Bello Roufai, Diana; Kamal, Maud; Borcoman, Edith; Le Tourneau, Christophe.
Afiliação
  • Vaflard P; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, 26 rue d'Ulm, 75005, Paris, France.
  • Paoletti X; Versailles St Quentin University and Institut Curie, Saint-Cloud, France.
  • Servois V; INSERM U900 Research unit, Saint-Cloud, France.
  • Tresca P; Department of Radiology, Institut Curie, Paris, France.
  • Pons-Tostivint E; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, 26 rue d'Ulm, 75005, Paris, France.
  • Sablin MP; Department of Medical Oncology, Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France.
  • Ricci F; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, 26 rue d'Ulm, 75005, Paris, France.
  • Loirat D; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, 26 rue d'Ulm, 75005, Paris, France.
  • Hescot S; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, 26 rue d'Ulm, 75005, Paris, France.
  • Torossian N; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, 26 rue d'Ulm, 75005, Paris, France.
  • Bello Roufai D; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, 26 rue d'Ulm, 75005, Paris, France.
  • Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, 26 rue d'Ulm, 75005, Paris, France.
  • Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, 26 rue d'Ulm, 75005, Paris, France.
  • Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, 26 rue d'Ulm, 75005, Paris, France.
Drugs R D ; 21(4): 399-406, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34562258
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Drugs R D Assunto da revista: TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Drugs R D Assunto da revista: TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França